I visited a Royal Horticultural Society garden recently, and one of the things the tour guide pointed out resonated with me. There were several newly-planted copses of trees that looked quite thin on the ground. When I asked how long it would take for these trees to become as big as some of the others in the area, I was told it would be over a hundred years.

And it’s this kind of long-term planning that I believe we are missing out on in the world of clinical trials.

Obviously planning for things that will be happening a hundred years from now isn’t going to be especially useful. But having a vision that stretches at least beyond the constraints of the current trial we’re working on, certainly seems like it could be a valuable approach for the industry to be taking.

You may also like

Biotech C-suites Should keep Patient Recruitment in Mind from the Outset
In biotech, a strong C-suite isn’t just about job titles - it’s about covering every part of the journey from discovery to delivery. Including being prepared to tackle one of the biggest ...
Key C-suite Roles for Biotech Success - The Chief Patient Recruitment Officer (CPRO)
While biotech companies have built C-suites with scientific, medical, financial, operational, and business expertise, a critical function has remained conspicuously absent - addressing one ...
Key C-suite Roles for Biotech Success - The Chief Business Officer (CBO)
The Chief Business Officer leads external strategy - licensing deals, identifying pharma partnerships, and developing long-term growth planning and market positioning strategies that ...